1044.7500 1.15 (0.11%)
NSE Sep 12, 2025 15:31 PM
Volume: 559.9K
 

1044.75
0.11%
Reliance Securities
ff Acquisition: CDH has acquired 51% stake in Dehradun-based Windlas Healthcare, which gives access to a USFDA-approved facility (oral solid; plain vanilla and niche products). CDH expects this facility to help in commercialisation of 20-30 products over next 2-3 years,...
Geojit BNP Paribas increased Buy price target of Zydus Lifesciences Ltd. to 1121.0 on 03 Sep, 2025.
More from Zydus Lifesciences Ltd.
Recommended